Yasuaki Arai, MD, FSIR

Guest researcher
National Cancer Center Hospital, Japan

Presentation(s):

• Extreme IR: Just Because It Happened, Doesn't Mean You Have To Take A Picture Of It

  Saturday, March 29, 2025
  1:00 PM – 4:00 PM CT

• Chemoembolization

  Sunday, March 30, 2025
  9:20 AM – 9:30 AM CT

• Opening Plenary Session with Gold Medalists, Leader in Innovation Awards and Dotter Lecture

  Sunday, March 30, 2025
  10:30 AM – 12:00 PM CT

• Outcomes by key prognostic factors in EMERALD-1: a Phase 3 study of durvalumab ± bevacizumab with transarterial chemoembolization (TACE) in participants with embolization-eligible unresectable hepatocellular carcinoma (uHCC)

  Tuesday, April 1, 2025
  4:03 PM – 4:12 PM CT